Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 19;4(5):267-271.
doi: 10.1002/iju5.12298. eCollection 2021 Sep.

A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy

Affiliations
Case Reports

A case of adenocarcinoma of the rete testis with durable response to cisplatin-based chemotherapy

Shunsuke Owa et al. IJU Case Rep. .

Abstract

Introduction: Adenocarcinoma of the rete testis is a rare malignancy with a poor prognosis. We report a case of adenocarcinoma of the rete testis with a durable response to cisplatin-based chemotherapy.

Case presentation: A 48-year-old man with Down syndrome (trisomy 21) presented with a 1-month history of painless swelling of the left scrotum. The physical examination revealed a left testis with a hydrocele associated with a tumor and enlarged pelvic and para-aortic lymph nodes. He underwent a radical orchiectomy. The specimen was diagnosed as adenocarcinoma of the rete testis. The patient received 7 cycles of chemotherapy (1 cycle of BEP and 6 cycles of EP) postoperatively. The metastatic lymph nodes were reduced in size for at least 12 months. Our patient with adenocarcinoma of the rete testis obtained an acceptable response to cisplatin-based chemotherapy.

Conclusion: We treated a patient with an adenocarcinoma of the rete testis who had an acceptable response to platinum-based chemotherapy.

Keywords: adenocarcinoma of the rete testis; cisplatin‐based chemotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Ultrasonography showed testicular enlargement with a mosaic appearance inside the hydrocele of the testis, which was suspicious for a testicular tumor. CT showed a testicular tumor with a maximum diameter of 6.2 cm inside the hydrocele of the testis. Metastases were found in the pelvic and pararenal aorta lymph nodes, with a maximum diameter of 6.1 cm.
Fig. 2
Fig. 2
Macroscopic findings. A dark red tumor showing small hemorrhagic areas was observed within the resected specimen. The tumor measured 45 × 50 × 60 mm.
Fig. 3
Fig. 3
(a) Histologically, tumor cells with a high nuclear‐to‐cytoplasm ratio grew in a sheet‐like pattern and showed extensive necrosis (bar = 200 µm). (b) Small foci of proliferating spindle‐shaped tumor cells are seen. In situ lesions were recognized in the rete testis (arrows) (bar = 100 µm).
Fig. 4
Fig. 4
Clinical course of the case. Chemotherapy was administered after orchiectomy. After the end of chemotherapy, the lymph node metastases continued to shrink.

References

    1. National Comprehensive Cancer Network . Plymouth meeting PA. NCCN Guidelines Version 1.2019 Testicular Cancer.
    1. Sanchez‐Chapado M, Angulo JC, Haas GP. Adenocarcinoma of the rete testis. Urology. 1995;46: 4:468–475. 10.1016/s0090-4295(99)80257-x - DOI - PubMed
    1. Newbold RR, Bullock BC, McLachlan JA. Lesions of the rete testis in mice exposed prenatally to diethylstilbestrol. Cancer Res. 1985; 45: 5145–50. https://pubmed.ncbi.nlm.nih.gov/4027990/ - PubMed
    1. Polanco C, Pantazis CG, Prieto R. Papillary adenocarcinoma of the rete testis with adjacent hyperplasia: a case report. Case Rep Clin Pathol. 2015;2: 2:41–46. 10.5430/crcp.v2n2p41 - DOI
    1. Stein JP, Freeman JA, Esrig D, Chandrasoma PT, Skinnerner DG. Papillary adenocarcinoma of the rete testis: A case report and review of the literature. Urology. 1994;44: 4:588–594. 10.1016/s0090-4295(94)80067-7 - DOI - PubMed

Publication types